Elizabeth P Schlaudecker1, Lilliam Ambroggio2, Monica M McNeal3, Fred D Finkelman4, Sing Sing Way3. 1. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. Electronic address: Elizabeth.Schlaudecker@cchmc.org. 2. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA; Division of Hospital Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA; Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. 3. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. 4. Department of Medicine, Cincinnati Veterans Affairs Medical Center, Division of Allergy, Immunology and Rheumatology, University of Cincinnati College of Medicine and Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Abstract
BACKGROUND: Influenza immunization is universally recommended during pregnancy to protect mothers and their offspring. However, pregnancy-induced shifts in vaccine responsiveness remain poorly defined. METHODS: Quantitative and qualitative shifts in the serological response to influenza vaccination were evaluated in healthy women throughout the course of pregnancy. Serum was obtained before and after vaccination among 71 pregnant and 67 non-pregnant women during the 2011-12 and 2012-13 influenza seasons. Serum hemagglutination inhibition (HAI) assay was used to investigate anti-influenza antibody responses by comparing pre-vaccine and post-vaccine geometric mean titers (GMTs) between groups for each antigen. IgG1, IgG2, IgG3, and IgG4 anti-influenza titers were also evaluated by enzyme-linked immunosorbent assay (ELISA). Pregnancy induced shifts in HAI titers and levels of each anti-influenza antibody isotype were evaluated using linear regression models. RESULTS: Post-vaccine GMTs at day 28 were significantly reduced for women vaccinated during pregnancy for A/California (H1N1) in 2011 (p = 0.027), A/Perth (H3N2) in 2011 (p = 0.037), and B/Wisconsin in 2012 (p = 0.039). Vaccine responses progressively declined with the initiation of vaccination later in pregnancy. Anti-H1N1 IgG1, IgG2, and IgG3 titers were reduced in pregnant women compared to non-pregnant controls, and these titers declined with pregnancy progression. The most striking differences were found for anti-H1N1 IgG1, where titers decreased by approximately 7% each week throughout pregnancy. CONCLUSIONS: HAI responses elicited by immunization were significantly reduced during pregnancy for three different influenza vaccine antigens. Anti-H1N1 IgG1 was significantly lower in pregnant women and decreased throughout the course of pregnancy. Waning serological responsiveness to influenza vaccination with the progression of human pregnancy has important translational implications for when immunization should be optimally administered during pregnancy.
BACKGROUND:Influenza immunization is universally recommended during pregnancy to protect mothers and their offspring. However, pregnancy-induced shifts in vaccine responsiveness remain poorly defined. METHODS: Quantitative and qualitative shifts in the serological response to influenza vaccination were evaluated in healthy women throughout the course of pregnancy. Serum was obtained before and after vaccination among 71 pregnant and 67 non-pregnant women during the 2011-12 and 2012-13 influenza seasons. Serum hemagglutination inhibition (HAI) assay was used to investigate anti-influenza antibody responses by comparing pre-vaccine and post-vaccine geometric mean titers (GMTs) between groups for each antigen. IgG1, IgG2, IgG3, and IgG4 anti-influenza titers were also evaluated by enzyme-linked immunosorbent assay (ELISA). Pregnancy induced shifts in HAI titers and levels of each anti-influenza antibody isotype were evaluated using linear regression models. RESULTS: Post-vaccine GMTs at day 28 were significantly reduced for women vaccinated during pregnancy for A/California (H1N1) in 2011 (p = 0.027), A/Perth (H3N2) in 2011 (p = 0.037), and B/Wisconsin in 2012 (p = 0.039). Vaccine responses progressively declined with the initiation of vaccination later in pregnancy. Anti-H1N1 IgG1, IgG2, and IgG3 titers were reduced in pregnant women compared to non-pregnant controls, and these titers declined with pregnancy progression. The most striking differences were found for anti-H1N1 IgG1, where titers decreased by approximately 7% each week throughout pregnancy. CONCLUSIONS: HAI responses elicited by immunization were significantly reduced during pregnancy for three different influenza vaccine antigens. Anti-H1N1 IgG1 was significantly lower in pregnant women and decreased throughout the course of pregnancy. Waning serological responsiveness to influenza vaccination with the progression of human pregnancy has important translational implications for when immunization should be optimally administered during pregnancy.
Authors: Demilade A Adedinsewo; Laila Noory; Robert A Bednarczyk; Mark C Steinhoff; Robert Davis; Chinelo Ogbuanu; Saad B Omer Journal: Vaccine Date: 2013-10-10 Impact factor: 3.641
Authors: Shabir A Madhi; Clare L Cutland; Locadiah Kuwanda; Adriana Weinberg; Andrea Hugo; Stephanie Jones; Peter V Adrian; Nadia van Niekerk; Florette Treurnicht; Justin R Ortiz; Marietjie Venter; Avy Violari; Kathleen M Neuzil; Eric A F Simões; Keith P Klugman; Marta C Nunes Journal: N Engl J Med Date: 2014-09-04 Impact factor: 91.245
Authors: G V Quinnan; F A Ennis; C U Tuazon; M A Wells; G M Butchko; R Armstrong; C McLaren; J F Manischewitz; S Kiley Journal: Infect Immun Date: 1980-11 Impact factor: 3.441
Authors: Saad B Omer; David Goodman; Mark C Steinhoff; Roger Rochat; Keith P Klugman; Barbara J Stoll; Usha Ramakrishnan Journal: PLoS Med Date: 2011-05-31 Impact factor: 11.069
Authors: Richard Apps; Yuri Kotliarov; Foo Cheung; Kyu Lee Han; Jinguo Chen; Angélique Biancotto; Ashley Babyak; Huizhi Zhou; Rongye Shi; Lisa Barnhart; Sharon M Osgood; Yasmine Belkaid; Steven M Holland; John S Tsang; Christa S Zerbe Journal: JCI Insight Date: 2020-04-09
Authors: Saad B Omer; Dayna R Clark; Shabir A Madhi; Milagritos D Tapia; Marta C Nunes; Clare L Cutland; Eric A F Simões; Anushka R Aqil; Joanne Katz; James M Tielsch; Mark C Steinhoff; Niteen Wairagkar Journal: Lancet Respir Med Date: 2020-06 Impact factor: 30.700
Authors: Bahaa Abu-Raya; Kirsten Maertens; Kathryn M Edwards; Saad B Omer; Janet A Englund; Katie L Flanagan; Matthew D Snape; Gayatri Amirthalingam; Elke Leuridan; Pierre Van Damme; Vana Papaevangelou; Odile Launay; Ron Dagan; Magda Campins; Anna Franca Cavaliere; Tiziana Frusca; Sofia Guidi; Miguel O'Ryan; Ulrich Heininger; Tina Tan; Ahmed R Alsuwaidi; Marco A Safadi; Luz M Vilca; Nasamon Wanlapakorn; Shabir A Madhi; Michelle L Giles; Roman Prymula; Shamez Ladhani; Federico Martinón-Torres; Litjen Tan; Lessandra Michelin; Giovanni Scambia; Nicola Principi; Susanna Esposito Journal: Front Immunol Date: 2020-06-24 Impact factor: 7.561